Literature DB >> 19672874

Integrative approach for prioritizing cancer genes in sporadic colon cancer.

James F Reid1, Manuela Gariboldi, Viktorija Sokolova, Patrizia Capobianco, Andrea Lampis, Federica Perrone, Stefano Signoroni, Aurora Costa, Ermanno Leo, Silvana Pilotti, Marco A Pierotti.   

Abstract

The current multistep carcinogenesis models of colon cancer do not fully capture the genetic heterogeneity of the disease, which is additionally complicated by the presence of passenger and driver genetic alterations. The aim of this study was to select in the context of this significant heterogeneity additional genes functionally related to colon cancer development. High-throughput copy number and gene expression data of 36 microsatellite stable sporadic colon cancers resected from patients of a single institution characterized for mutations in APC, KRAS, TP53 and loss of 18q were analyzed. Genes whose expression correlated with the underlying copy number pattern were selected, and their association with the above listed mutations and overall survival was evaluated. Gain of 20q was strongly associated with TP53 mutation, and overall survival with alterations on 7p, 8p, 13q, 18q, and 20q. An association with 18q loss and gain of 8q24 was also observed. New candidate genes with a potential role in colon cancer are PLCG1 on 20q, DBC1 on 8q21, and NDGR1 on 8p24. In addition, an unexpected pattern of loss and mutability was found in the region upstream of the KRAS gene. By integrating copy number alterations with gene expression and mutations in colon cancer associated genes, we have developed a strategy that identifies previously known molecular features and additional players in the molecular landscape of colon cancer. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672874     DOI: 10.1002/gcc.20697

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  27 in total

1.  Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.

Authors:  Yun-Chi Tang; Hui Yuwen; Kaiying Wang; Peter M Bruno; Kevin Bullock; Amy Deik; Stefano Santaguida; Marianna Trakala; Sarah J Pfau; Na Zhong; Tao Huang; Lan Wang; Clary B Clish; Michael T Hemann; Angelika Amon
Journal:  Cancer Res       Date:  2017-08-03       Impact factor: 12.701

2.  A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.

Authors:  Masamichi Imajo; Koichi Miyatake; Akira Iimura; Atsumu Miyamoto; Eisuke Nishida
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

Review 3.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

4.  Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.

Authors:  Lenora W M Loo; Maarit Tiirikainen; Iona Cheng; Annette Lum-Jones; Ann Seifried; James M Church; Robert Gryfe; Daniel J Weisenberger; Noralane M Lindor; Steven Gallinger; Robert W Haile; David J Duggan; Stephen N Thibodeau; Graham Casey; Loïc Le Marchand
Journal:  Genes Chromosomes Cancer       Date:  2013-01-23       Impact factor: 5.006

5.  DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.

Authors:  Yongguo Zhang; Yong Gu; Sumei Sha; Xiangyun Kong; Hongwu Zhu; Bin Xu; Yijun Li; Kaichun Wu
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

6.  DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Authors:  Hyun Jin Bae; Young Gyoon Chang; Ji Heon Noh; Jeong Kyu Kim; Jung Woo Eun; Kwang Hwa Jung; Min Gyu Kim; Qingyu Shen; Young Min Ahn; So Hee Kwon; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  Oncol Lett       Date:  2012-08-23       Impact factor: 2.967

7.  EMT is the dominant program in human colon cancer.

Authors:  Andre Loboda; Michael V Nebozhyn; James W Watters; Carolyne A Buser; Peter Martin Shaw; Pearl S Huang; Laura Van't Veer; Rob A E M Tollenaar; David B Jackson; Deepak Agrawal; Hongyue Dai; Timothy J Yeatman
Journal:  BMC Med Genomics       Date:  2011-01-20       Impact factor: 3.063

8.  Global transcriptome and sequenome analysis of formalin-fixed salivary epithelial-myoepithelial carcinoma specimens.

Authors:  Isabel Fonseca; Achim Bell; Khalida Wani; Diana Bell
Journal:  Genes Chromosomes Cancer       Date:  2014-12-29       Impact factor: 5.006

9.  PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Authors:  George Poulogiannis; Rebecca E McIntyre; Maria Dimitriadi; John R Apps; Catherine H Wilson; Koichi Ichimura; Feijun Luo; Lewis C Cantley; Andrew H Wyllie; David J Adams; Mark J Arends
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

Review 10.  Integration of genome scale data for identifying new players in colorectal cancer.

Authors:  Viktorija Sokolova; Elisabetta Crippa; Manuela Gariboldi
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.